Do FBT and GNMX hold the same stocks?

By their latest filings, 22% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, FBT or GNMX?

FBT has 25% of its weight in S&P 500 names and GNMX has 31%, so GNMX differs more from the index.

Which is cheaper, FBT or GNMX?

FBT charges 0.55% a year and GNMX charges 0.35%, so GNMX is cheaper. Fees come from each fund's prospectus.

Data as of Nov 4, 2026.

Thematic ETFs

FBT vs GNMX: Holdings Overlap & Returns

Share on X Download as PDF

FBT and GNMX hold 22% of their weight in the same names.

askIQ about this page

askIQ about FBT and GNMX

Net assets: $3.1bn on Nov 3, 2026 for First Trust NYSE Arca Biotechnology Index Fund, and $1.3m on Nov 4, 2026 for Corgi Genomics & Precision Medicine ETF.

FBT on its own →GNMX on its own →

At a glance

24.8%

FBT in the S&P 500

31.0%

GNMX in the S&P 500

+47.0%

FBT total return, 1 year

+48.3%

GNMX total return, 6 months

FBT · 1 year to Nov 4, 2026 75% of its weight is outside the S&P 500

25% of FBT's weight is in S&P 500 companies and 75% is outside the index. Holdings as of Nov 3, 2026.

GNMX · 6 months to Nov 4, 2026 69% of its weight is outside the S&P 500

31% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.

Pair scorecard

GNMX costs 0.20 points a year less; FBT is far larger, $3.1bn against $1.3m.

FBT vs GNMX: Holdings Overlap & Returns
Measure	FBT	GNMX
Return
Measure	FBT	GNMX
Total return, 1 year	+47.0%	not published
Benchmark
Measure	FBT	GNMX
What it tracks	Biotech	Genomics and gene editing
Cost and size
Measure	FBT	GNMX
Expense ratio	0.55%	0.35%
Net assets, as of Nov 3, 2026	$3.1bn	$1.3m
Holdings
Measure	FBT	GNMX
Holdings in common	22%

Method

What they share

22%

By the books each fund has filed, FBT and GNMX hold 22% of their money in the same securities at the same weight. Holdings dated Nov 3, 2026 and Nov 4, 2026.

50%

0 half 100%

half

22% in common

Positions both hold · largest shared weight first FBT GNMX

Genmab A/S (ADR) 4.81% 4.39%

Vertex Pharmaceuticals Incorporated 3.34% 6.04%

Illumina, Inc. 2.75% 3.92%

Incyte Corporation 3.35% 2.70%

Bio-Techne Corporation 3.22% 2.10%

BioMarin Pharmaceutical Inc. 3.26% 1.89%

Alnylam Pharmaceuticals, Inc. 2.21% 1.69%

Veracyte, Inc. 3.57% 1.46%

NeoGenomics, Inc. 3.30% 1.31%

Only in one fund ↓

Only in FBT

Regeneron Pharmaceuticals, Inc. 4.18%

Exelixis, Inc. 3.88%

Halozyme Therapeutics, Inc. 3.74%

Neurocrine Biosciences, Inc. 3.71%

Alkermes Plc 3.61%

Amgen Inc. 3.57%

Gilead Sciences, Inc. 3.56%

Biogen Inc. 3.54%

Only in GNMX

Moderna Inc 11.24%

Thermo Fisher Scientific Inc 8.88%

Guardant Health Inc 3.45%

Revolution Medicines Inc 3.24%

10X Genomics Inc 2.87%

CareDx Inc 2.43%

Twist Bioscience Corp 2.32%

GRAIL Inc 2.26%

Check overlap with more funds →

Window by window

Window by window: FBT vs GNMX: Holdings Overlap & Returns
	Total return
Window	FBT	GNMX
3 months	+12.2%	+24.3%
6 months	+30.5%	+48.3%
1 year	+47.0%	–
3 years	+100.5%	–
Since launchNot the same days: FBT Jun 2006 · GNMX May 2026	+1,349.5%	+48.3%

– means no data for this window. Open this comparison in the app →

Side by side

FBT First Trust NYSE Arca Biotechnology Index Fund · Holds 30 stocks in biotech, 25% of its weight in S&P 500 companies GNMX Corgi Genomics & Precision Medicine ETF · Holds 57 stocks in genomics and gene editing, 31% of its weight in S&P 500 companies

Issuer First Trust Corgi

Theme Biotech Genomics and gene editing

In the S&P 500 24.8% 31.0%

Active share vs the S&P 500 99.1% 99.4%

In the Nasdaq-100 16.9% 7.7%

Holdings 30 57

Top ten, share of the fund 38.2% 49.2%

Expense ratio 0.55% 0.35%

Fee for the differing part 0.55% 0.35%

Total return, 1 year +47.0% +48.3% (since launch, May 6, 2026)

vs its benchmark not measured not measured

Below its high −0.3% −4.2%

Net assets, FBT as of Nov 3, 2026 and GNMX as of Nov 4, 2026 $3.1bn $1.3m

As of Nov 4, 2026. Source: ETFIQ.

22% of the two portfolios are the same securities at the same weight.

Alert

About each fund

FBT

By weight, 25% of FBT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 38% of the fund across 30 positions, as published by its issuer for Nov 3, 2026. Over the year to Nov 4, 2026 the fund returned +47.0% with distributions reinvested.

GNMX

By weight, 31% of GNMX's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 49% of the fund across 57 positions, as published by its issuer for Nov 4, 2026. Since it first traded on May 6, 2026 the fund returned +48.3% with distributions reinvested.

Questions people ask

Do FBT and GNMX hold the same stocks?: By their latest filings, 22% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, FBT or GNMX?: FBT has 25% of its weight in S&P 500 names and GNMX has 31%, so GNMX differs more from the index.
Which is cheaper, FBT or GNMX?: FBT charges 0.55% a year and GNMX charges 0.35%, so GNMX is cheaper. Fees come from each fund's prospectus.

Other comparisons

FBT vs GNOM FBT vs IDNA FBT vs ARKG FBT vs IBBQ GNMX vs IBB GNMX vs PBPH GNMX vs XBI GNMX vs PBE

Where to next

All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →FBT on its own →GNMX on its own →FBT dividend history →FBT holdings →GNMX holdings →Method →Standards and sources →

Sources and dates

FBT filings on SEC EDGAR ↗

FBT prospectus with the expense ratio (SEC) ↗

First Trust page for FBT ↗

GNMX filings on SEC EDGAR ↗

GNMX prospectus with the expense ratio (SEC) ↗

Corgi website ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, FBT against GNMX, data as of Nov 4, 2026. https://etfiq.com/compare/themes/fbt-vs-gnmx

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.